| Anticancer activity of biogenerated silver nanoparticles: an integrated proteomic investigation M Buttacavoli, NN Albanese, G Di Cara, R Alduina, C Faleri, M Gallo, ... Oncotarget 9 (11), 9685, 2018 | 188 | 2018 |
| Expression of alpha-enolase (ENO1), Myc promoter-binding protein-1 (MBP-1) and matrix metalloproteinases (MMP-2 and MMP-9) reflect the nature and aggressiveness of breast tumors P Cancemi, M Buttacavoli, E Roz, S Feo International journal of molecular sciences 20 (16), 3952, 2019 | 69 | 2019 |
| Proteomic patterns of cultured breast cancer cells and epithelial mammary cells IDA PUCCI‐MINAFRA, S Fontana, P Cancemi, G Alaimo, S Minafra Annals of the New York Academy of Sciences 963 (1), 122-139, 2002 | 65 | 2002 |
| Integrated multi-omics investigations of metalloproteinases in colon cancer: Focus on MMP2 and MMP9 M Buttacavoli, G Di Cara, E Roz, I Pucci-Minafra, S Feo, P Cancemi International journal of molecular sciences 22 (22), 12389, 2021 | 57 | 2021 |
| Mesenchymal and induced pluripotent stem cells-derived extracellular vesicles: the new frontier for regenerative medicine? MM Barreca, P Cancemi, F Geraci Cells 9 (5), 1163, 2020 | 54 | 2020 |
| Proteomic differentiation pattern in the U937 cell line L Minafra, G Di Cara, NN Albanese, P Cancemi Leukemia research 35 (2), 226-236, 2011 | 52 | 2011 |
| The role of matrix metalloproteinases (MMP‐2 and MMP‐9) in ageing and longevity: Focus on sicilian long‐living individuals (LLIs) P Cancemi, A Aiello, G Accardi, R Caldarella, G Candore, C Caruso, ... Mediators of Inflammation 2020 (1), 8635158, 2020 | 50 | 2020 |
| Proteomic analysis of protein components in periodontal ligament fibroblasts E Reichenberg, M Redlich, P Cancemi, B Zaks, S Pitaru, S Fontana, ... Journal of periodontology 76 (10), 1645-1653, 2005 | 49 | 2005 |
| Expanding the protein catalogue in the proteome reference map of human breast cancer cells I Pucci‐Minafra, P Cancemi, S Fontana, L Minafra, S Feo, M Becchi, ... Proteomics 6 (8), 2609-2625, 2006 | 48 | 2006 |
| Large-scale proteomic identification of S100 proteins in breast cancer tissues P Cancemi, G Di Cara, NN Albanese, F Costantini, MR Marabeti, R Musso, ... BMC cancer 10, 1-12, 2010 | 45 | 2010 |
| A multiomics analysis of S100 protein family in breast cancer P Cancemi, M Buttacavoli, G Di Cara, NN Albanese, S Bivona, ... Oncotarget 9 (49), 29064, 2018 | 44 | 2018 |
| New synthetic nitro-pyrrolomycins as promising antibacterial and anticancer agents MV Raimondi, A Presentato, G Li Petri, M Buttacavoli, A Ribaudo, ... Antibiotics 9 (6), 292, 2020 | 36 | 2020 |
| Graphene oxide carboxymethylcellulose nanocomposite for dressing materials ML Saladino, M Markowska, C Carmone, P Cancemi, R Alduina, ... Materials 13 (8), 1980, 2020 | 36 | 2020 |
| A contribution to breast cancer cell proteomics: detection of new sequences I Pucci‐Minafra, S Fontana, P Cancemi, L Basiricò, S Caricato, S Minafra PROTEOMICS: International Edition 2 (7), 919-927, 2002 | 36 | 2002 |
| New protein clustering of breast cancer tissue proteomics using actin content as a cellularity indicator I Pucci-Minafra, P Cancemi, NN Albanese, G Di Cara, MR Marabeti, ... Journal of proteome research 7 (4), 1412-1418, 2008 | 35 | 2008 |
| When functionalization becomes useful: Ionic liquids with a “sweet” appended moiety demonstrate drastically reduced toxicological effects F Billeci, F D’Anna, M Feroci, P Cancemi, S Feo, A Forlino, F Tonnelli, ... ACS Sustainable Chemistry & Engineering 8 (2), 926-938, 2019 | 33 | 2019 |
| Proteomic profiling of 13 paired ductal infiltrating breast carcinomas and non‐tumoral adjacent counterparts I Pucci‐Minafra, P Cancemi, MR Marabeti, NN Albanese, G Di Cara, ... PROTEOMICS–Clinical Applications 1 (1), 118-129, 2007 | 31 | 2007 |
| The effects of structural changes on the anti-microbial and anti-proliferative activities of diimidazolium salts P Cancemi, M Buttacavoli, F D'Anna, S Feo, RM Fontana, R Noto, ... New Journal of Chemistry 41 (9), 3574-3585, 2017 | 30 | 2017 |
| Proteomic profiling of trastuzumab (Herceptin®)-sensitive and-resistant SKBR-3 breast cancer cells G Di Cara, G Marengo, NN Albanese, MR Marabeti, R Musso, P Cancemi, ... Anticancer Research 33 (2), 489-503, 2013 | 30 | 2013 |
| Extracellular vesicles shed by melanoma cells contain a modified form of H1. 0 linker histone and H1. 0 mRNA-binding proteins G Schiera, CM Di Liegro, V Puleo, O Colletta, A Fricano, P Cancemi, ... International journal of oncology 49 (5), 1807-1814, 2016 | 28 | 2016 |
